FOXP3 and lung cancer: 2.7. Treatment with MTR OralGem Chemotherapy Enhances Antitumor Effector Responses and Reduces Infiltration of CD4+Foxp3+ Treg Cells in the Syngeneic Mouse Lung Cancer Model